Introductory Chapter: The Rationale for a Multimodal Approach to Pain Treatment by Cascella, Marco
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Introductory Chapter: The 
Rationale for a Multimodal 
Approach to Pain Treatment
Marco Cascella
1. Common issues in acute and chronic pain management
The symptom pain is a perception affected by complex interconnections of 
biological, psychological, and social factors. Analgesic monotherapy can often 
provide pain relief in clinical conditions featuring non-severe pain. In other circum-
stances, such as those characterized by intractable cancer pain, or concerning acute/
chronic non-cancer neuropathic pain, the intensity and quality of the pain require 
individualized multidrug approaches, with different analgesics and adjuvants used 
in combination according to clinical practice guidelines published by international 
and regional professional associations [1]. Moreover, because pharmacological 
strategies may not be able to successfully treat all patients with acute or chronic 
pain, nonpharmacological strategies should be included in the analgesic program, 
supporting and strengthening drug therapy [2]. Again, especially, chronic pain 
represents a dynamic experience, profoundly changeable in a spatial-temporal man-
ner; thus, standardized and fixed protocols are not universally applicable for pain 
therapy. From these premises, the individualized, dynamic, and multicomponent 
pathway is summarized by the concept of the multimodal approach to pain manage-
ment and represents a real revolution in this field of medicine. This optimization 
strategy can allow managing the pain by treating this symptom in its variegated 
clinical expressions through multiple interventions. According to the concept of 
multimodal therapy, the objective of pain relief is possible by targeting different 
sites of the nociceptive pathway [3] and by managing the galaxy of pain-related 
conditions through pharmacologic and nonpharmacologic modalities [4]. However, 
several considerations should be addressed in order to better understand its rational 
application for both acute (e.g., postoperative) and chronic pain management.
1.1 The unmet need of postoperative pain relief
According to the Lancet’s data, more than 230 million people undergo surgery 
each year worldwide and this huge number tends to increase year over year [5]. 
Postoperative pain is a typical example of acute pain and, probably, it represents 
the classic example of unmet need in surgery as up to 80% of postsurgical patients 
experience pain which in 10–20% of cases is described as severe [6]. This topic is 
of paramount importance, as inadequately controlled pain impairs quality of life 
(QoL) and functional recovery, increases the risk of postsurgical complications, 
and lengthens the time of hospitalization. Increased morbidity and prolonged opi-
oid use during and after hospitalization are serious problems which call for effective 
preventive interventions. Furthermore, treating chronic pain induced by ineffective 
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acute pain management increases the cost of care, enormously [7]. From these data, 
it is clear that the commonly used strategies to address postoperative pain are very 
often inadequate.
1.2 The issue of pain chronitization
Undertreated acute postoperative pain is the main cause determining the 
development of postsurgical chronic pain (PSCP), which is difficult to treat and 
often invalidating in form. The pain chronitization is the final stage of a complex 
pathogenetic cascade. Summarizing, these mechanisms involve the activation of 
peripheral and central sensitization pathways. Data from a wide number of pre-
clinical investigations demonstrated that activation and sensitization of peripheral 
nociceptors, spinal dorsal horn neurons, and central nervous system (CNS) brain 
areas may occur [8]. The role of specific peripheral mechanisms contributing to 
pain after surgical incision and manipulation has been investigated as well. The 
literature on the topic encompasses an incredible number of studies on nociceptors, 
molecular mechanisms, fiber sensitization processes, inflammatory cytokines, 
and so on [9–13]. While according to a classical point of view, the CNS involve-
ment is strictly related to the mechanisms of chronic pain; however, it may result 
in difficulty to identify the borderline between acute and chronic pain. There are 
many good reasons to believe that many gaps such as the role of the environment 
(i.e., epigenetic) and genetics are not still well explained. Again, no clear criteria 
for diagnosing central sensitization have been recognized. The chronicity of pain 
is the effect of changes in pain processing through transcription and transduction 
processes. Preclinical studies suggested that alterations in the mRNA expression 
occur within the first 42–48 hours after surgery [14]. These sensitization processes 
seem to be quite rapid, at least in the experimental field. Thus, postoperative pain 
is a convoluted process engaging both the peripheral nervous system (PNS) and the 
CNS and, in turn, the exact distinction between acute and chronic postoperative 
pain is not always easy to establish.
1.3 Toward an early and combined strategy
Rather than dissecting the precise pathophysiology of acute and chronic pain, 
our knowledge on the matter must be translated in the most effective way to limit 
acute pain and to prevent mechanisms of sensitization. For these aims, all our 
“analgesic arsenal” must be defused as soon as possible, and before that surgery 
may trigger the first fuse. For instance, it has been demonstrated that tailored 
preoperative educational programs reduced postoperative opioid requirement and 
shortened the length of stay [15]. Furthermore, several self-management programs 
focused on patient’s education and training may reduce risk factors (e.g., lifestyle-
related), enhance protective factors, and, finally, prevent pain chronitization [16]. 
As a consequence, individualized programs for perioperative pain management can 
be performed by acting simultaneously on different targets or implementing differ-
ent strategies according to the timing.
1.4 The opioid crisis
Ineffective management of perioperative pain and poorly controlled postopera-
tive pain may induce development of PSCP, increased opioid prescription and 
use, until opioid addiction. Because the opioids epidemic in the United States and 
Canada is a dramatic phenomenon which has been responsible for up to 70,000 
drug overdose deaths, in 2017 [17], the time has come to look at more effective 
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solutions and less harmful approaches capable of inducing optimal pain relief com-
bined with lessening opioid use, opioid prescriptions, and reduced opioid-related 
complications. Controlled investigations and evidence-based analysis demonstrated 
that multimodal approaches to postoperative pain improved analgesia and lowered 
opioid consumption is several clinical settings such as those underwent orthopedic 
[18] or colorectal surgery [19].
1.5 Chronic pain
These problems, linked to a lack of efficacy and to a criticality due to the use 
of opioids, do not only concern the postoperative pain chapter but also involve the 
management of chronic pain in its two sides of the coin, chronic cancer pain and 
chronic non-cancer pain. To understand the numerical terms of the matter, chronic 
pain is among the most common reasons for seeking medical care because it is 
reported by up 50% of patients seen in primary care [20]. Of note, chronic pain 
with neuropathic features, which often represents a hard task for clinicians, seems 
to be more common in the general population than earlier reported [21]. Because in 
cancer patients, pain has a multifactorial etiology and is quite a dynamic process, its 
management should be conducted through a careful combination of pharmacologi-
cal agents with nonpharmacological strategies. This dynamical approach should be 
based on pain intensity and the complexity of symptoms, pain pathophysiology, 
and presence of comorbidities.
2. Features of the multimodal approaches to pain management
The concept of “multimodal” analgesia was introduced by Kehlet and Dahl, in 
1993 [22]. This approach is based on the use of two or more distinct methods or 
drugs to treat pain rather than using opioids, or other strategies, alone. The rationale 
is that by combining medications and techniques with different mechanisms and 
sites of action, better pain relief can be achieved, with reduced side effects [23]. 
Different combinations of analgesic medications, adjuvants, and procedures can act 
on different sites and pathways in an additive or synergistic fashion. Clinicians may 
choose among a wide range of options included in several categories: pharmaco-
logic, physical medicine, education and behavioral approaches, interventional, and 
surgical modalities. In the surgical setting, anesthesiologists may combine regional 
anesthetics, and/or nonopioid analgesics, such as nonsteroidal anti-inflammatory 
drugs (NSAIDs), cyclooxygenase-2 (COX2) inhibitors, NMDA-receptor antagonists, 
and antiepileptic, and antidepressant medications with or without conventional opi-
oids. On the other hand, chronic cancer and non-cancer pain chronic cancer treat-
ment often requires the involvement of a multidisciplinary team which combines 
resources based on the patient’s needs, obtaining an individually tailored program.
2.1 Surgical settings
Multimodal approaches to pain management can be included among more 
complex systematic processes adopted for managing the whole perioperative 
course. The Enhanced Recovery After Surgery (ERAS) pathway, for instance, is a 
multidisciplinary model of care born with the aim of guaranteeing optimal recov-
ery and an early and safe return to daily activities after surgery. The pathway is a 
patient-tailored process provided by a team of surgeons, anesthesiologists, nurses, 
nutritionists, and physical therapists. In this scenario, the perioperative pain man-
agement is a keystone of the whole pathway [24]. Indeed, reduced need for opioids 
From Conventional to Innovative Approaches for Pain Treatment
4
through regional anesthetic block used in addition to general anesthesia during sur-
gery, or other minimally invasive approaches, may be effective for both pain relief 
and enhanced recovery target [25]. Apart from the ERAS strategy, another recent 
approach to perioperative pain management is the so-called opioid-free anesthesia 
(OFA) [26]. This term refers to a fascinating option for anesthesia administration 
that maximizes the patient’s comfort (including pain relief) while eliminating the 
unwanted side effects of opioids. Through this model, no intraoperative systemic, 
neuraxial, or intracavitary opioid is administered during the anesthetic course. The 
rationale of the OFA model is the avoidance of the opioid-induced hyperalgesia 
phenomenon, a paradoxical effect in which opioid therapy enhances or aggravates 
preexisting pain [27], the reduced occurrence of postoperative delirium, and 
postoperative cognitive dysfunction in elderly [28, 29] and in high-risk patients 
[30]. Furthermore, the OFA technique seems to be appropriate for minimizing 
respiratory depression in patients that have impaired respiratory function (e.g., due 
to sleep apnea, or obesity), for reducing postoperative nausea and vomiting, and 
for treating patients who have chronic pain conditions, or are on chronic opioid 
therapy, or opioid addiction [31, 32]. Although the effect of opioids on cancer 
recurrence or progression remains an open issue [33], the OFA approach can be 
considered as a protective strategy against cancer progression [34]. In the surgical 
setting, it is possible to obtain a multimodal strategy without completely avoid-
ing opioids. Low-dose opioids can be combined with one or more additional pain 
management methods (e.g., peripheral nerve blocks and neuraxial analgesia) and/
or medications such as acetaminophen, steroids, gabapentin/pregabalin, NSAIDs, 
dexmedetomidine, intravenous lidocaine, COX-2 inhibitors, or ketamine. Recently, 
Cozowicz et al. [35] demonstrated that this approach was correlated with a reduc-
tion in opioid use, postoperative complications, and less resource utilization. Again, 
multimodal analgesia may reduce the occurrence of PSCP, even when expressed as 
postsurgery pain syndrome [36], although the link between perioperative analgesic 
modes and the postoperative chronitization of pain should be better investigated 
[37]. The challenge of the OFA or the opioid-sparing regimens remains the choice 
of medication pathway in terms of number, the timing of use, and doses useful 
in different patient subgroups. While the use of a single drug (e.g., intravenous 
acetaminophen or methylprednisolone) was not associated with decreased opioids 
consumption [38], complex regimens featuring numerous medications may only 
increase drug-related side effects without improving outcomes.
2.2 Chronic cancer pain: beyond the analgesic ladder
In 1986, the World Health Organization (WHO) developed the classic three-
step ladder model based on the use of analgesics for pain management in accor-
dance with pain intensity in a linear movement directed toward the high or low 
steps of the ladder [39]. Subsequently, it was proposed a further step concerning 
interventional methods such as neurosurgical procedures (e.g., neuromodula-
tion, nerve blocks, brain stimulators, and nerve lysis) robustly recommended for 
managing persistent pain even following the use of strong opioids. This revised 
four-step path can be adopted in a bidirectional way on the basis of the type of 
pain and its intensity [40]. Other attempts to modify the ladder strategy have also 
been proposed. According to the neuromatrix theory, chronic pain represents 
a multidimensional experience induced by the activation of a neural network 
(“neurosignature patterns”) extensively distributed in the CNS [41]. From these 
premises, Leung hypothetically revised the original analgesic WHO ladder into a 
new analgesic path illustrated as a platform [42]. In this model, pain management 
followed a three-dimensional perspective including different areas of expertise 
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that, in a multimodal fashion, can be combined with classical analgesics, on the 
basis of the pain condition. Despite its novelty, Leung’s system seems to be lacking 
in completeness because it does not consider the dynamic perspective. The Cuomo 
et al. [43] “trolley analgesic model” is focused on individualized tailored therapies 
with dynamic multimodal approaches which are modulated according to the pain 
intensity, the physiopathology of pain, the multiplicity of symptoms, the presence 
of comorbidities, and psychological status and the patient’s social context. The 
pharmacological agents and the nonpharmacological methods are included in dif-
ferent drawers of the trolley. It is possible to draw on one, or more, drawers of the 
trolley, and to choose within the contents of each drawer the most useful therapeu-
tic method. According to the patient’s needs, therapists can close or open different 
drawers, in a dynamic fashion.
2.3 Chronic non-cancer pain: toward a winning strategy
Chronic non-cancer pain conditions such as low back pain (LBP), osteoar-
thritis, headache, and neuropathic pain represent a significant problem in terms 
of psychosocial and socioeconomic consequences [44]. Due to the complexity 
of clinical features and multiple underlying mechanisms, this issue requires a 
multimodal approach. Since the 1980s, Kohles et al. [45] proposed a combined 
(multimodal) strategy focused on medical, behavioral, physical, and educational 
programs. Through this approach, defined as “functional restoration,” the restoring 
of physical and psychological performances was obtained by the involvement of a 
multidisciplinary team composed of clinicians from a variety of medical disciplines 
(e.g., pain therapists, neurologists, orthopedics, rheumatologists), psychologists 
and psychiatrists, nurses, physical, and occupational therapists [46]. More recently, 
a task force of the German International Association for the Study of Pain (IASP) 
chapter has defined the principles of this approach, in terms of resources and oper-
ating methods [47]. Currently, the multimodal path has been widely recognized as 
winning strategy for addressing several chronic non-cancer pain conditions such as 
LBP, headache, and fibromyalgia although several obstacles still limit its routinely 
clinical application [48].
3. Conclusion
Multimodal approaches through the combined use of multiple modalities in 
analgesic protocols have the potential to offer a significant improvement in pain 
management for different acute, or chronic, clinical settings. Concerning periop-
erative pain management, included or not among ERAS or OFA pathways, mul-
timodal modes can allow reducing opioid use, opioid prescriptions, and common 
opioid-related side effects, improving, in turn, outcomes. It seems that multimodal 
pain management may be able to prevent the development of chronic postsurgical 
pain conditions. Moreover, different attempts to better frame chronic pain in its 
many components, and for an effective treatment through a holistic approach, are 
being made to address the matter. Thus, the combined use of multiple modalities in 
analgesic protocols is worldwide encouraged. However, further research is needed 
to evaluate optimal multimodal regimens in terms of medications, doses, and 
timing (including the duration) of the administration, as well as to offer data useful 
for evidence-based practice. Finally, because lack of training (e.g., for invasive 
techniques or new techniques in regional anesthesia) and poor sources are huge 
obstacles for a routine application of multimodal approaches, identification of key 
barriers for their implementation seems to be a research priority.
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